Life Sciences

China is striving to become the global leader in biopharmaceuticals, but many of its policy steps are “innovation mercantilist” in nature. This not only is expected to threaten U.S. leadership, but also slow global life sciences innovation, with negative consequences for cures and treatments.
Life Sciences
Check a box to narrow search for individual content items that cover numerous issues.
April 24, 2018
Twenty-five case studies underscore how innovators in developing countries—often enabled by robust IP rights—are achieving advances in life sciences and healthcare that benefit people around the world.
April 24, 2018
Please join ITIF and the Center for the Protection of Intellectual Property for an event releasing a new report that documents 25 cases of primarily developing-world entrepreneurs meeting global health challenges by “innovating for health.” The event will discuss what policies, including intellectual property, are needed to underpin successful life-sciences innovation in both the developed and developing world and feature presentations from several developing-country healthcare innovators who are leveraging IP, science, and technology to create a better world.
March 26, 2018
America’s lead in life sciences is being challenged. Other countries are aggressively seeking to attract and grow companies with innovation-based tax incentives, a range of firm-specific enticements, increased government research funding, improved IP protections, and streamlined regulatory approval processes. The federal government should act to ensure U.S. life sciences remain competitive.
February 12, 2018
Life-sciences companies grow best in locations that can combine qualities like a good business environment, skilled workers, strong research universities, and available capital. Strengthening these and related factors can give states a stronger competitive advantage.
December 4, 2017
For the U.S. government to restore National Institutes of Health funding to a level comparable to 2003, it would have had to allocate an additional $11.6 billion dollars last year, writes John Wu in Innovation Files.
November 28, 2017
The number of technology-based start-ups surged 47 percent in the last decade. These firms still account for a relatively small share of all businesses, but they have an outsized impact on economic growth, because they provide better-paying, longer-lasting jobs than other start-ups, and they contribute more to innovation, productivity, and competitiveness.
November 16, 2017
Previously, there were few HPV tests well suited to developing countries, but a new product—Xpert HPV—changes this by offering an accurate, real-time, self-contained, and easy to use molecular testing mechanism that can be used at the point-of-care.
September 12, 2017
In a presentation to a roundtable gathering of international think tanks in New York City, Stephen Ezell argued we are entering an era of renewed biomedical innovation marked by a wide range of new-to-the-world treatments for cancers, rare and chronic diseases, and other disorders.
August 31, 2017
President Widodo promised a renewed focus on innovation and economic growth. But his government has undermined its own strategic goals by badly weakening intellectual property laws that are critical for innovative industries are to thrive.
July 10, 2017
When doctors have better access to medicinal information through electronic drug referencing systems, they prescribe newly released generics up to two months sooner, writes John Wu in Innovation Files.

Pages